CD44 and central nervous system cancer: In addition, the addition of exogenous HA also partially reversed the decline in cell viability caused by low concentrations (3 μg/ml) of the CD44 antibody, but did not reverse the effect of high concentrations of the CD44 antibody (6 μg/ml) in glioma cells (Fig. 2C, Supplementary Fig. 2B).